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ACTI VATION OF I NTEGRIN a2 I N HUMAN ()EIlMAL FIBIlOIII.ASTS III' PI)GF ANI) PMA. 
I XII and R. A F C lark, Depl Derm, SUNY, Slnny Bmo.k, NY. . . 
Int egrins mediale cell ad hesion 10 eX II:acelllllar . mal~·IX. Reglll~tlon of IIIt eg~," 
expression is il11l)Ortanl in cell differe nllallon, n~l gra ll()n a nd sk l.n hOl11eos tas ls. 
a2p I inlcgrin, a co ll agen receptor ex pressed ,o n I~brohl:ls t s ( fob ), IS ~'cqUl rcd for 
these cell s to contrac t co ll agen ge ls, an III vit ro l1lo<l C~ -o0f .dcl mal wound 
contraction . Previolls ly, Oli O' la b delll ons lral ed Ih a l 1'0(,1· s llIlIlIlat cd. FI> to 
contract collagen gels and incrcasc:d a l cxprcssiOl~ . To 1I1u lcI'stand T11 cchaTllsl11s by 
w hi ch POGr regulates (12 IllRNA le\'cl, we trnns lc nll y trans fcclcd human dermal 
Fb with an a 2 prolllolel' (I kb)-CAT plas lll id ~onslrll c! , I~'ca l cd wilh PDGF a nd 
a n a lyzed for CAT acl ivil y. The a 2 1"'llmlll er-dlrecled C A l level was Increased by 
PDGF. Therefore, PDGF-induced increase of 0.2 IIIR NA s le:l dy-s lal e level was, a t 
lenst pnrliall )', clu e to transcriptiona l ndivatioll . . . Pi\~!A ,.a r~ aC llv~ll O" or gene 
express ion throu gh a rcgu lal o ry e l cm~ nl C:l l1 ~d I RI" S lm!la ~ l y. III cr eased ~2 
transcription . Since this protnolcr regIOn cons ists 01 two 11~ E sll es, sy nthell ~ 
oligonucleotides werc L1 sed in gel mobilit y shift assays to dcterrnlne wheth er PDGI· 
induced DNA bindin g 10 TH E. Uolh PDC F :lIld P MA in creased TRE bindin~ 4 
times higher than cont rol. Although but.h ;'lppc..':.Il'ed to lI1.c.':ease ex2 f::ic il e ~x pr~sSlOn 
v ia TRE sHes. Th e activation IlI cchalH STIIS ,-'ou lcl hc dlll crcnt. I~ XanlllH1 t l{U1 or 
protein synthesis req uiremcn t deOlollslralcd. lhal P))(;y' ~limulati()n (~f 02 mRN:\ 
synth esis was abolished in th e pr('sc'I1('(' 01 cydohcX lTlllcic, a protem s)'nthcsis 
inhibitor wh ereas PMA stimulation was nol. \Vhil c PlVIA is well k nown 10 
funclion ihrnllgh TRE s il es by prolein killa~e C palhw:,)" PDGF a~li":lt!on of a2 
gene ex press ion was inhibit NI by gCIlI .'i t ell1 , a tyros ll1 c klll:.tse II1I11bl~or : In 
summary PDGF a nd P MA s lill1ul nlcd a 2 mR NA leve l by Ira nscrrpllOll ul 
acti va ti on' m ccha nism probabl y Ihrough TRE s il es. lI owevel', PDGF an d ~MA 
appear to activa te th c sa U1C regulatory clement through (IIrrc rcn ~ pathways. 1 hus, 
highly organized regulntory tnct'i lanisl11s conlrol n2 ~t.: l1 e (!Xpr eSSIOI1. 
Interaction of the Terminal Comp l ement Proteins with 
Sialic-Acid Conta ining Molecules of the Erythrocyte . ~ 
Whitlow a nd P. Marshall. Manhattan VA a nd NVmlC. 
Complement is depos ite d in a number of skin 
diseases . One of the major ways complement exerts 
biologica l activity i s via the formation of trans-
membrane cha nnels by the terminal complement proteins 
C5b-9 . C5b- 9 is kno\o/n to interact \o/ith membranes via 
hydrophobic forces. The purpose of this investi~ation is 
to investigate the role of ionic forces , spec1f1cally 
sialic ac id residues , in the interaction of C5b-9 with 
the e rythrocyte cell membrane . Treat~ent of ~rythrocytes 
with V. Cholerae sialidase reduces s1al1c aC1d from 2 . 0 
~M/M9 prote in to 0.4 MM/M9 protein and reduces C5b- 9 
channe l s pe r cel l from 0.4 5 to 0.18. R~sial lYlation.of 
the erythrocytes using T . cruzi trans-s1a l1dase p~rt1ally 
restores sialic acid to a l eve l of 1 MM/M9 prote1n and 
increases cha nnels to 0.39 channels per cell. We examined 
the abi lity of the two major sialylated molecules of the 
erythrocyte surface , glycophorin and gangliosides to 
interact with C5b- 7. Gangliosides G~l" GM, and GM3 ~ll 
inhibit C5b- 7 deposit ion on cells. Mutant gangl10s1des 
l ack ing the carboxylic acid r es idue have no activity. 
Native glycophorin a lso inhibits C5b-7 deposition and 
desialyl a tion with v. Cholerae sialidase reduces the 
inhibition by 50%. We conclude that C5b-7 binds to 
s ialylated molecul es on the e rythrocyte surface , and that 
ionic interactions p l aya role in C5b-7 deposition. 
THE EFFECTS OF N-ACETYLCYSTEINE AND L-CYSTEINE ON PORPHYRIN/HEME 
BIOSYNTHETIC PATHWAY IN ENDOTHELIAL CELLS. pan He Susana Be har Joan E 
Robert s nod Henry W Lim, Dermatology Service. New York VA Med ical Center. 
New York, NY; The Ronald O. Pe relman Dept. of Dermatology , NYU Sc hool of 
Medicine, New York . NY; Dept. of Chemistry , Fordham University , New York , NY . 
Our previous study has demonstrated that a transformed human dermal 
microvascul ar e ndothelial ce ll line IHMEC-1) loaded w ith 5-ami nol evulinic acid (ALAI 
and ultraviolet A (UVA) and blue light irradiation inhibits ferrochelatase (FeC) 
activity, resu lting in a further increase in porphyrin accumulation. It has been 
re ported tha t N-ace tylcysteine (NAC) and L-cysteine (LC) cou ld lessen the 
photosensitivity associated with photodynamic therapy (PDT) or erythropoietic 
protoporphyria (EPPl, Thi s study investigated the effects of NAC and LC on 
porphyrin accumula tion and FeC activity in ALA-loaded irradia ted HMEC-1 cells. 
Cu ltured HMEC-1 cells were incubated with NAC (0.1 -10.0 mM) or with LC (0.1 -5.0 
mM) for 24 h. ALA (0 .6 mM) was added to the ce ll cu lture in the last 2 h 
in cubation. The ce ll s then were irradiated (0.68 kJ /m' at 402-4 13 nm) follow ed by a 
second ALA (0 .3 mM) incubation for 24 h. Porphyrin accumulation was determined 
spectrofluorometricall y. FeC activity was measured immediately after the irradia tion . 
Porphyrin accumu lation was suppressed in the presence of NAC (30.9%-58.0 % 
suppression) . Fee ac tivity was increased (3.0 nmol /mg protein in the presence of 
5.0 mM NAC vs. 1. 2 nmollmg protein in the abse nce of NAC) . Suppression of 
porphyrin accumulat ion was also obse rved in the prese nce of LC (18 .7%-28.7 % 
suppression), but there was no increase in FeC activi ty. These data indicate that 
NAC and LC may have protective effec ts on porphyrin and irradiation indLlced 
photochemical react ions. which occur in HMEC· ' cells in vitro. 
ANTI-LAMlNIN 5 IgG INDUCES SUBEPIDERMAL BLISTERS IN ADULT 
BALB/c MICE. Z La7.a rova C Yee and K B Yancey, NIH, Bethesda, MD. 
Laminin 5 is a protein associated with anchoring fLIaments in human epidennal 
basement membrane that has been shown to be targeted by IgG anti-basement 
membrane autoantibodies in patients with ~ fonn of cicauicial pemphigoid. 
Moreover, it has recently been shown that passive transfer of anti-Iaminin 5 (but not 
control) IgG causes subepidennal blisters in nonnal as well as complement- and mast 
cell-deficient newborn mice. To further examine the pathogenic activity of anti-
laminin 5 antibodies in vivo as well as develop a more practical animal model of this 
human blistering disease, we have injected the epilated flanks of adult BALB/c mice 
with purified rabbit anti-Iaminin 5 IgG that is known to cause subepithelial blisters in 
neonatal mice. Mice (n=8) receiving a single intrndennal injection of 5 mg of 
purified anti-Iaminin 5 IgG develop erythema, erosions, and crusts at injection si tes 
within 24 hours. Lighl microscopy studies of these injection sites demonstrate foci 
of epidennal separation at 6 hours, frank subepithelial blisters at 12 hours, and 
epidennal necrosis 48 hours following injection. By direct immunofluorescence 
microscopy, depOsits of rabbit IgG and murine C3 are found in epidennal BM at 
sites injected wi th anti-Iaminin 5 IgG. In contrast. no specific clinical, histologic. or 
immunopathologic alterations are observed in other BALB/c mice challenged 
intrndennally wi th identical amounts and volumes of purified nonnal rabbit IgG 
(n=8) or bovine serum albumin (n=8) (controls). These s tudies show tllat laminin 5 
plays a key role in maintaining adhesion of epidennis to cpidennal basement 
membrane in adult as well as newborn murine skin. show that anti-Iaminin 5 
antibodies can induce subepidennal blisters in adull murine skin, and establish a 
practical animal model that can be used to further define disease mechanisms and 
IrCaUllent modali ties. 
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INTERACTION OF HUMAN DERMAL MICROVASCULAR ENDOTHELIAL CEllS WITH 
PROVISIONAL EXTRACEllULAR MATRIX PROTEINS. D. Newman, R.A.F. Clark, 
M. Mosesson, and M.G. Tonnesen, Depts Derm & Med, SUNY, Stony Brook, 
NY, Sinai Samaritan Med Ctr, Milwaukee, WI , & VAMC , Northport, NY. 
During initiation of wound repair microvascular endothelial cells (MEC) 
migrate into the the tibrinogen (Fg) and fibronectin (Fn) rich clot. Adherence 
to provisional extrace llular matrix (ECM) proteins is an essential component 
of MEC migration. The adherence of human dermal MEC (HDMEC) to Fn 
and Fg were analyzed after incubation in protein-coated microtiter wells for 1 
hour at 37°C. Adhesion and spreading were determined microscopically and 
quantitated spectrophotometrically after staining with crystal violet. HDMEC 
adhered to Fn and Fg but not 8SA coated wells. HDMEC spreading was 
significantly greater on Fn compared to Fg. Adhesion to Fn was unaffected 
by 1 mM RGD (GRGDSP), but spreading was reduced. Adhesion to Fg was 
completely blocked by ,::0.03 mM RGD. Fg contains two RGD sites, one on 
the N-terminal end (residues 95-97), the other on the carboxyl end (residues 
573-574) of the Cl chain. Equivalent HDMEC adhesion was observed to a 
subfraction of Fg missing the carboxyl RGD site as to intact Fg. To our 
knowledge this is the first report of MEC adhesion to Fg containing only the 
N-term inal RGD site. In conclusion, HDMEC adhered to and spread on Fn 
surfaces, while they attached with limited spreading on Fg. Spreading on Fn 
and adherence to Fg were RGD dependent We speculate HDMEC interact 
with normal and partially denatured provisional ECM proteins to facilitate 
angiogenesis during granulation tissue formation in cutaneous wounds. . 
ULTRAVIOLET RADIATION INDUCED EGF RECEI'TOR-MEIlIATED 
SI GNALING DOES NOT INVOLVE RECEI'TOR IlIMEIUZATlON BUT 
RA I'IDLY STIM ULATES TYROSINE KINASE ACTIVITY. E.Yaping, E. 
Levit, R. Moraro V. DeLeo, Columbia University College of Physicians & 
Surgeons, New York, NY. 
Ultraviolet (UV) irradiation as a complete carcinogen is capable of inducing both 
acute and chronic cutaneous change includi ng sk in cancer, sunburn. imm une 
modulati on and photoagillg. It has been suggested thut some of these changes are 
mediated through membrane related signaling pathways. Ligand induced 
phosphorylation and dimeriwtion of epidermal growth factor (EGF) receptor is 
thought to be one of the crucia l steps in the process of receptor-mediated signa li ng. 
Our studi cs show that both UVA(320-400rlm) and UV8(290-320nm) irrad iation 
can induce rapid tyrosine phosphorylation of EGF receptor in A43 1 cell s and 
normal hu man epiderma l kcratinocytcs. Th is phosphorylation is in a dosc-
dependent manner. We found however that UV irrad iation docs not induce EGf 
receptor dimeriwti on in either cell type. Moreover, a tyrosine kinase inhibi tor, 
Tyrphostin, blocked the UV induced tyrosine phosphorylation of EGF receplOr. 
Our results indicate that the UV induced EG f receptor-mediated signaling 
pathway does not involve receptor dimcrizati on but that EGF receptor tyrosine 
ki nase o r o ther tyrosine kinase ac ti vity may play an importan t ro le in the signal 
transduction pathway. In addition, the UV induced EGf receplOr phosphorylation 
may be a regulatory event linking signali ng and UV induced cutaneOliS di sc'lses. 
(Abstract for 1.1.0. OCI. 1995 meeting at NYU) 
KINETICS OF APOPTOStS INDUCTION IN l YMPHOCYTE BY UVA AND PHOTO-
CHEMOTHERAPY. ~o Alain H Rook Francis P Gasparro and Benjamin A 
~, Depl. of Dermatology, School of Medicine. University of Pennsylvania, Philadelphia, 
PA and Depl. of Surgery, School of Medicine, University of Pennsylvania, Philadelphia, PA 
While previous studies have indicaled Ihal DNA damage as a result of 8-methoxypsoralen 
(8-MOP) and UVA treatment leads to cell dealh, th is study establishes the minimum 
concentrations of 8-MOP and UVA necessary to induce apoptosis in peripheral blood 
lymphocytes. In order to assess apoptosls, we used fl ow cytometry to examine changes in 
light scatter measurements as well as internucleosomal DNA fragmentation by an adaptation 
of the TUNEL assay. Generation of a dose response curve showed that Ihe minimum 
combination of UVA and 8-MOP that was necessary to induce greater than background 
tevels of apoptosis within 24 hours of treatment was 1 J/cm2 UVA and 50 ng/ml of 8-MOP. 
We previously showed that cell division of T cells can almost be completely blocked by 1 
J/cm2 UVA in the presence of 50 ng/ml of S-MOP. Moreover, these data are consistent with 
clinical observations thai plasma levels of S-MOP of Sezary Synd rome patients treated with 
ExP must exceed 50 ng/mt during the pe riod of UVA irradiation (1.0-2.0 J/cm2) in order to 
exert a therapeutic effecl. -
A striking observations was that UVA alone at doses" 2 J/cm2, but not B-MOP alone (0-
300 ng/ml), induced significant apoptosis in the PBl within 24 hours. While the percentage 
of apoptotic PBl Induced by UVA alone was not as great as Ihat of B-MOP and UVA in 
combination (approx. 50% grealer with B-MOP), this observalion may have both positive and 
negative ramifications regarding the role of UVA in the induction of apoptosis in cu taneously 
trafficking lymphocytes. The low "apoptotic threshotd- of tymphocytes to UVA and PUVA 
may be a critical mechanism in the effecliveness of Ihese therapies for psoriasis and olher 
cutaneous lymphocyte-infiltrating diseases. However, these observations may be an 
importanl mechanism to underslanding epidemiological studies that Indicate a link between 
the development of non-Hodgkin's lymphoma (NHl) and sunlight exposure. 
T H E JOURNAL OF INVESTIGATIVE DERMATOLOGY 
BULLOUS PEMPHIGOID IS ASSOCIATED WITH IL-4 AND IL-5 DEPOSITION 
IN VIVO. MJ..Rico!,...C..Benning.!,-'ll1_Slreilei~alt, New York University, the 
New York VA Medical Center, New York, NY· and Duke University, Durham, NC' . 
We have recently analyzed skin biopsies from patients wi th bullous pemphigoid (BP) , 
pemphigus and other skin diseases for the presence of Type I (IL-2, IFNy) and Type 
2 (IL-4, IL-5) cylokines by immunohistochemistry. Skin biopsies from patients with 
BP express the Type 2 cytokines, IL-4 and IL-5. IL-5 local ized in a linear band at the 
basement membrane (BM) in lesional skin in 4/6 patienls and perilesional skin in 4/12 
patients. IL-4 was present in mononuclear cell s in the dermal infiltrates of all lesional 
and 6/12 periJesional skin biopsies. VCAM was detected in 5 perilesional BP biopsies 
and correlated with the expression of I L -4. Lesional skin biopsies from patienls with 
pemphigus demonstrated IL-2 (5/6 palients) , IFNy (4/6 patients) , and IL-4 (6/6 
patients) in mononuclear cells in the dermal infiltrate. No cytokine staining was 
observed in biopsies from patients with other inflammalory skin diseases (n =5). In all 
biopsies , cells in the inflammatory infiltrate were CD3 positive, CD4 positive; CDS 
positive cells were rarely seen. Recombinant human IL-5 did not bind to normal or BP 
skin, suggesting that specific receptors or activation si tes present in lesional BP skin are 
required for IL-5 localization at Ule basement membrane. Thi s study demonslrates the 
presence of Type 2 cytokines, including deposition of lL-5 in a linear band at the BM, 
in patients with BP and a mixed pallem of cytokine expression in pemphigus. This 
pallem of eytokine expression is unique among autoimmune diseases reported to date 
and may be relevant in Ihe pathogenesis of disease, including i sotype swilching and 
eosinoph il recruitment and aClivalion . 
l11e Use or Mat'fck Epi-Dennal Equivalents For Prediction or Irritation Potential. 
Lauren Bernharer, Chandni Juneja and Katharine Manin. 
III Vitro Pharmacology and Toxicology Group. 
Johnson & Johnson Consumer Products Worldwide, Skillman , NJ, USA . 
Abstr .. ct 
The need exists for a rapid , accurate in \ilro screening protocol predktive fo r human skin 
irritation in response 10 topicaUy applied prodUClS. TIle Epi- IOO. EpiDerm™ Human Skin 
Model System produced by MatTck Corporation (Ashland, MA) is be ing investigated for this 
purpose. This system consists of normal, human-derived epidermal kcratinocytcs (NHEK). 
grown on pcnnc.lble cell culture insens to fonn a multilayered, highly differentiated model 
of the human epidemli s. Keratinocytes. the major cell type in skin , have the capacity to 
synthes ize and release potent immunomodu lalOry cytokines aft er exposure to irri tants . 
Literature indicates that these pro-inflammalory mediators play an impo nant role in both 
demlaJ irritation and irritant cOfllact dennatitis. TIley are responsible for the skin's primary 
response, whkh consists of edema, erythema and cell infil tration. Currentl y marketed 
ELISA assay ki ts allow the safe, rnpid and accurate mca.5urement o f several key cytokines. 
TIle extent of mediaton released from exposed equivalents should be a good indicalOr of 
irritation potential. Keratinocyte derived Interleukin- l a hal an imponam role in the 
infl:mllnatory response, being involved in the initiation and maintenance of acute 
inflammation. In this study , a Modified Oraizc Rabbit Primary Irril;uion Test (POI) was 
completed for three concentrations of SOS in a cream base (0 .3, 1.0 and 3.0 me/g) and a 
Placebo (Cream Base only) . TIIC results were compared to two ill vitro assays in which Bpi -
100 equivalents were exposetJ to conccntrations of SOS in cream base for one hour, washed 
thoroughly and maintained fur 24 hours. Media was collected after the 24 hour incubation 
and hIL- Ia, OM-CSP, TNFa and PGEz content mc.15Urcd . TIle hIL- la release was dose 
dependent fo r the level of SOS exposure . Correlation of the In vitro log pg/ mL hIL-la with 
the ill lim POI Index were R = O.829 for Trial I and R= 0.993 for Trial 2. [f the two 111 
Vilro trials are compared for the same conccntrnlions of SOS, than R=O.854 . 
